Dr. Reddy's Laboratories
186 hedge funds and large institutions have $1.48B invested in Dr. Reddy's Laboratories in 2020 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 54 increasing their positions, 66 reducing their positions, and 17 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
106% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 17
29% more capital invested
Capital invested by funds: $1.15B → $1.48B (+$337M)
10% more funds holding
Funds holding: 169 → 186 (+17)
0.83% less ownership
Funds ownership: 65.08% → 64.24% (-0.83%)
18% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 66
18% less call options, than puts
Call options by funds: $1.84M | Put options by funds: $2.25M
Top Buyers
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$10.9M |
| 2 |
Morgan Stanley
New York
|
+$8.12M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$7.95M |
| 4 |
Lazard Asset Management
New York
|
+$7.48M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.39M |
Top Sellers
| 1 |
BlackRock
New York
|
-$9.62M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$8.17M |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$6.44M |
| 4 |
JP Morgan Chase
New York
|
-$6.28M |
| 5 |
Goldman Sachs
New York
|
-$6.22M |
RDY Hedge Fund Activity: Q3 2020 in Review
186 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2020, worth a combined $1.48B — up 29% from $1.15B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new RDY positions and 17 closed out — a net gain of 18 holders — while 54 added to existing stakes and 66 trimmed.
The largest buyer was Bank of Montreal, adding an estimated $10.9M. The largest seller was BlackRock, cutting an estimated $9.62M.
- 186 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2020, up from 169 in Q2 2020.
- Funds reported $1.48B of Dr. Reddy's Laboratories stock for Q3 2020, up 29% quarter-over-quarter.
- 35 funds opened new Dr. Reddy's Laboratories positions in Q3 2020 and 17 closed out, a net change of +18 holders.
- The largest Dr. Reddy's Laboratories buyer in Q3 2020 was Bank of Montreal, an estimated $10.9M added.
- The largest Dr. Reddy's Laboratories seller in Q3 2020 was BlackRock, an estimated $9.62M sold.
Based on aggregated 13F filings for Q3 2020.